Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on: December 20,2023

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on:December 20,2023

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on: December 18,2023

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on:December 18,2023

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on: May 16,2024

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on:May 16,2024

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on: March 17,2025

Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy

Updated on:March 17,2025

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on: December 25,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on:December 25,2023

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on: January 25,2024

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on:January 25,2024

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on: December 22,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on:December 22,2023

Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformation

FEBRUARY 28, 2024by Luis Sandoval,Cold Spring Harbor LaboratoryA cross-section of a mouse's early-stage pancreatic tumor. CSHL scientists discovered that early pancreatic cancer cells depend

Updated on: March 15,2024

Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformation

FEBRUARY 28, 2024by Luis Sandoval,Cold Spring Harbor LaboratoryA cross-section of a mouse's early-stage pancreatic tumor. CSHL scientists discovered that early pancreatic cancer cells depend

Updated on:March 15,2024

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on: January 04,2024

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on:January 04,2024

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review

Updated on: January 28,2024

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review

Updated on:January 28,2024

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on: January 08,2024

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on:January 08,2024